Insulet Co. (NASDAQ:PODD – Get Rating) CFO Wayde D. Mcmillan sold 1,455 shares of the company’s stock in a transaction on Friday, April 1st. The shares were sold at an average price of $275.60, for a total value of $400,998.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which […]
Cwm LLC purchased a new stake in Insulet Co. (NASDAQ:PODD – Get Rating) in the fourth quarter, according to its most recent filing with the SEC. The fund purchased 81,384 shares of the medical instruments supplier’s stock, valued at approximately $21,654,000. Cwm LLC owned about 0.12% of Insulet at the end of the most recent […]
Equities analysts expect Insulet Co. (NASDAQ:PODD – Get Rating) to announce $286.90 million in sales for the current quarter, according to Zacks Investment Research. Eight analysts have issued estimates for Insulet’s earnings. The lowest sales estimate is $284.10 million and the highest is $291.00 million. Insulet posted sales of $252.30 million in the same quarter […]
Aegon Asset Management UK PLC boosted its stake in shares of Insulet Co. (NASDAQ:PODD – Get Rating) by 3.1% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 276,025 shares of the medical instruments supplier’s stock after acquiring an additional 8,195 shares during the period. Insulet comprises about […]
Spire Wealth Management increased its stake in shares of Insulet Co. (NASDAQ:PODD – Get Rating) by 33.6% during the 4th quarter, HoldingsChannel.com reports. The fund owned 445 shares of the medical instruments supplier’s stock after purchasing an additional 112 shares during the period. Spire Wealth Management’s holdings in Insulet were worth $118,000 as of its […]